Immunomodulatory mediators IL-33, soluble ST2, IL-10, IFN-<i>γ</i> in the serum of patients with oral potentially malignant disorders and oral squamous cell carcinoma.

Front Oral Health · 2026 · PMC13136695 · PMID 42088894

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp < 0.001actually significant

Kruskal–Wallis analysis revealed highly significant differences among the three groups for all immune mediators ( p < 0.001), and pairwise comparisons confirmed significant differences between each group (HC vs.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Immunomodulatory mediators IL-33, soluble ST2, IL-10, IFN-&lt;i&gt;γ&lt;/i&gt; in the serum of patients with oral potentially malignant disorders and oral squamous cell carcinoma.

The sentences

Immunomodulatory mediators IL-33, soluble ST2, IL-10, IFN-<i>γ</i> in the serum of patients with oral potentially malignant disorders and oral squamous cell carcinoma.